These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6165055)

  • 1. Antibodies as carriers for oncostatic materials.
    Arnon R; Hurwitz E; Sela M
    Recent Results Cancer Res; 1980; 75():236-45. PubMed ID: 6165055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher antitumor efficacy of daunomycin when linked to dextran: in vivo and in vitro studies.
    Bernstein A; Hurwitz E; Maron R; Arnon R; Sela M; Wilchek M
    J Natl Cancer Inst; 1978 Feb; 60(2):379-84. PubMed ID: 621754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed tumor chemotherapy.
    Arnon R
    Compr Ther; 1978 Apr; 4(4):68-73. PubMed ID: 348397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of anti-tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastase. In vitro and in vivo studies with Lewis lung carcinoma.
    Hurwitz E; Schechter B; Arnon R; Sela M
    Int J Cancer; 1979 Oct; 24(4):461-70. PubMed ID: 393637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.
    Arnon R; Sela M
    Immunol Rev; 1982; 62():5-27. PubMed ID: 7042540
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic effect of treatment with polyclonal or monoclonal antibodies to alpha-fetoprotein that have been conjugated to daunomycin via a dextran bridge: studies with an alpha-fetoprotein-producing rat hepatoma tumor model.
    Tsukada Y; Ohkawa K; Hibi N
    Cancer Res; 1987 Aug; 47(16):4293-5. PubMed ID: 2440563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti cancer effect of antibiotic-AFP-purified antibody conjugates].
    Tsukada Y; Hibi N; Ohkawa K; Uchino J; Hirai H
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2653-8. PubMed ID: 6210058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.
    Levy R; Hurwitz E; Maron R; Arnon R; Sela M
    Cancer Res; 1975 May; 35(5):1182-6. PubMed ID: 164280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fab dimers of antitumor immunoglobulins as covalent carriers of daunomycin.
    Hurwitz E; Maron R; Arnon R; Sela M
    Cancer Biochem Biophys; 1976 May; 1(4):197-202. PubMed ID: 975021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic activity and pharmacokinetics of adriamycin and daunomycin in tumor bearing mice.
    Martini A; Donelli NG; Mantovani A; Pacciarini MA; Fogar-Ottaviano EF; Morasca L; Garattini S; Spreafico FS
    Oncology; 1977; 34(4):173-8. PubMed ID: 917449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect in vivo of chemotherapeutic drug--antibody conjugates in two murine experimental tumor systems.
    Hurwitz E; Maron R; Bernstein A; Wilchek M; Sela M; Arnon R
    Int J Cancer; 1978 Jun; 21(6):747-55. PubMed ID: 669855
    [No Abstract]   [Full Text] [Related]  

  • 12. Effective antitumour conjugates of alkylating drug and antibody using dextran as the intermediate carrier.
    Rowland GF
    Eur J Cancer (1965); 1977 Jun; 13(6):593-6. PubMed ID: 880966
    [No Abstract]   [Full Text] [Related]  

  • 13. The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities.
    Hurwitz E; Levy R; Maron R; Wilchek M; Arnon R; Sela M
    Cancer Res; 1975 May; 35(5):1175-81. PubMed ID: 164279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA, liposomes, and proteins as carriers for antitumoral drugs.
    Trouet A; Baurain R; Deprez-De Campeneere D; Layton D; Masquelier M
    Recent Results Cancer Res; 1980; 75():229-35. PubMed ID: 7232835
    [No Abstract]   [Full Text] [Related]  

  • 15. Daunomycin--immunoglobulin conjugates, uptake and activity in vitro.
    Hurwitz E; Maron R; Arnon R; Wilchek M; Sela M
    Eur J Cancer (1965); 1978 Nov; 14(11):1213-20. PubMed ID: 738327
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
    Duncan R; Kopecková-Rejmanová P; Strohalm J; Hume I; Cable HC; Pohl J; Lloyd JB; Kopecek J
    Br J Cancer; 1987 Feb; 55(2):165-74. PubMed ID: 3468994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates.
    Biddle WC; Haruta Y; Seon BK; Henderson ES; Sarcione EJ
    Leuk Res; 1989; 13(8):699-707. PubMed ID: 2529399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed chemotherapy with a drug bound to anti-idiotypic antibody to a lymphoma cell-surface IgM.
    Hurwitz E; Kashi R; Burowsky D; Arnon R; Haimovich J
    Int J Cancer; 1983 Jun; 31(6):745-8. PubMed ID: 6862683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic, antiviral, and antitumor activity of some derivatives of daunomycin (NSC-82151).
    Di Marco A; Casazza AM; Dasdia T; Giuliani F; Lenaz L; Necco A; Soranzo C
    Cancer Chemother Rep; 1973; 57(3):269-74. PubMed ID: 4751254
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a conjugate of daunomycin and purified polyclonal or monoclonal antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
    Tsukada Y; Hurwitz E; Kashi R; Sela M; Hibi N; Hara A; Hirai H
    Ann N Y Acad Sci; 1983; 417():262-9. PubMed ID: 6200034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.